Sarepta Therapeutics | Resultat Før Skatt

Pre Tax Profit Endring Dato
Acadia Pharmaceuticals USD 21M 18.7M 2024-03
Agios Pharmaceuticals USD -81549000 14.39M 2024-03
Alnylam Pharmaceuticals USD -63587000 74.1M 2024-03
Amgen USD -68000000 3.09B 2024-03
Avrobio USD -6808000 12.93M 2024-03
Biogen USD 464.8M 336.9M 2024-03
BioMarin Pharmaceutical USD 105.55M 72.22M 2024-03
Daiichi Sankyo JPY 97.75B 47.78B 2023-12
Eli Lilly USD 2.54B 52.4M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
Incyte USD 236.16M 82.99M 2024-03
Insmed USD -156502000 28.56M 2024-03
Ionis Pharmaceuticals USD -142728000 139.73M 2024-03
Moderna USD -1165000000 1.24B 2024-03
Neurocrine Biosciences USD 34.5M 163.7M 2024-03
Pfizer USD 3.42B 4.67B 2024-03
PTC Therapeutics USD -84696000 65.2M 2024-03
Regeneron Pharmaceuticals USD 700.7M 698.9M 2024-03
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 1.35B 2.61B 2024-03
Sarepta Therapeutics USD 41.45M 74.62M 2024-03
Ultragenyx Pharmaceutical USD -170229000 43.34M 2024-03
Vertex Pharmaceuticals USD 1.28B 31.7M 2024-03



Sarepta Therapeutics Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.